Veracyte Veracyte Expects HalioDx Acquisition to Drive International Market Growth Premium The firm also shared validation data at ASCO 2021 on its nasal swab classifier to help guide treatment decisions for patients with indeterminate lung nodules. Veracyte Bladder Cancer Test Receives Medicare Coverage The patient must be a candidate for multiple potential treatments with varying levels of intensity or multiple therapies. GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month. Veracyte to Acquire HalioDx for €260M Veracyte said the acquisition will help accelerate its in vitro diagnostic test development and manufacturing operations in Europe. Veracyte Q1 Revenues Up 18 Percent; CEO Transition Underway The firm posted first quarter revenues of $36.7 million, up from $31.1 million a year ago and above analysts' average estimate of $32.7 million. Apr 15, 2021 Veracyte Preliminary Q1 Revenues Up 16 to 19 Percent, CFO to Retire Mar 26, 2021 People in the News: New Appointments at Genomind, Veracyte, Rebus Biosystems, More Feb 17, 2021 Veracyte Q4 2020 Revenues Rise 16 Percent Feb 5, 2021 Veracyte Prices $550M Public Offering of Common Stock Feb 4, 2021 Veracyte to Use Decipher Biosciences Acquisition to Expand Commercial Cancer Testing Reach Premium Feb 3, 2021 Veracyte to Acquire Decipher Biosciences for $600M; Prelim Q4 Revenues Grow 14 to 18 Percent Dec 22, 2020 Bayer, Veracyte to Identify Therapy-Resistant Thyroid Cancer Patients Dec 1, 2020 Veracyte, Twist Bioscience Lead November GenomeWeb Index on Strong Earnings Growth Nov 3, 2020 Veracyte Q3 Revenues Flat but Beat Analyst Estimates Oct 15, 2020 Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests Sep 18, 2020 People in the News: New Appointments at Quidel, NeoGenomics, Veracyte, More Aug 5, 2020 Veracyte Prices $180M Public Stock Offering Aug 4, 2020 GenomeWeb Index Up 13 Percent in July as Investors Cheer COVID Dx Development Jul 30, 2020 Veracyte Q2 Revenues Fall 31 Percent Jul 29, 2020 Veracyte, MaviDx Ink Agreement to Develop COVID-19 Assay Jun 1, 2020 Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details May 14, 2020 CareDx, Veracyte to Commercialize Organ Transplant Rejection Tests on nCounter Platform May 6, 2020 Veracyte Q1 Revenues Rise 5 Percent as Net Loss Soars on Higher Expenses Apr 23, 2020 Veracyte Licenses Lung Disease Genomic Classifier From Yale University Apr 17, 2020 Veracyte Preliminary Q1 Revenues up 3 to 7 Percent, Firm Withdraws 2020 Guidance Load More Breaking News Pediatric Medulloblastoma Subgroups May Benefit from Lower-Dose Radiation Therapy Space Radiation Shows Limited Effects on Mammalian Sperm DNA, Fertility Bluestar Genomics Sues Former Consultant, Ludwig Institute for Cancer Research Over IP Ownership New Products Posted to GenomeWeb: 10x Genomics, Swift Biosciences, Agilent Technologies, More In Brief This Week: Quantum-Si, TGen, Yale, and More People in the News: New Appointments at Invitae, PGDx, Oxford Nanopore, PacBio, More The Scan Fertility Fraud Found Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today. Ties Between Vigorous Exercise, ALS in Genetically At-Risk People Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports. Test Warning The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK. Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.